TMJ Bioengineering Conference

颞下颌关节(TMJ)，或颌关节，是人体最复杂的关节之一。尽管有大量的患者和与过多的TMJ疾病相关的显著发病率，但与骨科社区感兴趣的关节相比，TMJ的研究一直很少。与骨科社区不同，在TMJ研究社区中，工程师、科学家和临床医生之间没有有组织的连续性。为了应对这种明显缺乏协调的公开沟通，我们提议举行TMJ生物工程会议。TMJ生物工程大会定于2006年5月25日至27日在科罗拉多州博尔德举行。这次会议将是此类会议的第一次，将患者和外科医生聚集在一起，为生物工程师提供具体的指导。会议的总体目标是为生物工程师提供一个独特的论坛，与临床医生和患者交流想法和观点，努力确定治疗TMJ障碍的当代挑战，并制定利用生物工程应对这些挑战的策略。这一目标将通过以下具体目标来实现：1)从临床社区获得生物工程指令， 2)将患者群体代表确定的需求纳入这些生物工程指令，以及3)为当前最先进的治疗和科学知识设定基准。我们已经选择了首批外科医生和患者发布AIMS 1和2的指令-美国TMJ外科医生协会主席将根据他们年会上形成的优先问题共识发表主旨演讲，TMJ协会患者组织主席将根据之前的会议和数十年与TMJ患者的经验和互动发表主旨演讲。TMJ当代知识的基准将在38年前进行评估 在组织工程、生物力学、生物学和临床治疗会议上发言。这些指令的传播和重要讨论的摘要将发表在一篇文章中，这篇文章将发表在生物医学工程年鉴上，这是主要的生物工程专业学会的官方期刊。迫切需要这次会议，它不仅将为未来的TMJ特定生物工程会议奠定基础，而且还将通过发展连续性、促进合作和吸引更多人才到该领域来作为TMJ研究的里程碑扩展。

The temporomandibular joint (TMJ), or jaw joint, is one of the most complex joints in the body. Despite the tremendous patient population and the significant morbidity related to a plethora of TMJ disorders, the TMJ has been poorly studied in comparison to joints of interest to the orthopaedic community. Unlike the orthopaedic community, there is no organized continuity between engineers, scientists and clinicians in the TMJ research community. In response to this striking lack of coordinated open communication, we are proposing to hold a TMJ Bioengineering Conference. The TMJ Bioengineering Conference is scheduled for May 25-27, 2006 near Boulder, CO. This meeting will be the first of its kind, bringing patients and surgeons together to deliver specific directives to bioengineers. The overall meeting objective is to provide a unique forum for bioengineers to exchange ideas and perspectives with clinicians and patients, in an effort to identify contemporary challenges with treating TMJ disorders and to devise strategies to address these challenges with bioengineering. This objective will be addressed by the following Specific Aims: 1) To obtain bioengineering directives from the clinical community, 2) To incorporate into these bioengineering directives needs as identified by representatives of the patient population, and 3) To set a benchmark for current state-of-the-art treatments and scientific knowledge. We have selected the premiere groups of surgeons and patients to issue the directives of aims 1 and 2?the president of the American Society of TMJ Surgeons will deliver a keynote address based on a consensus of priority issues formulated at their annual meeting, and the president of the TMJ Association patient organization will deliver a keynote address based on previous meetings and decades of experience and interaction with TMJ patients. A benchmark for contemporary knowledge of the TMJ will be assessed by 38 speakers in sessions on tissue engineering, biomechanics, biology and clinical treatment. Dissemination of these directives and a summary of salient discussions will be featured in an article that will go to the Annals of Biomedical Engineering, the official journal of the main bioengineering professional society, the Biomedical Engineering Society. There is a compelling need for this conference, which will set the stage not only for future TMJ-specific bioengineering meetings, but will also serve as a milestone expansion in TMJ research by developing continuity, fostering collaborations, and drawing more talent to the field.